Bryan Wahl

Insider Reports History

Entity
Individual
Location
15440 Laguna Canyon Road, Suite 160, Irvine, CA
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bryan Wahl:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. General Counsel Common Stock 51.7K $2.59M $50.11 Mar 20, 2025 Direct
Tarsus Pharmaceuticals, Inc. General Counsel Stock Option (right to buy) 30.6K $337K $10.99 Mar 5, 2025 Direct
Tarsus Pharmaceuticals, Inc. General Counsel Restricted Stock Units 21.5K $277K $12.89 Mar 15, 2025 Direct

Insider Reports Filed by Bryan Wahl

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARS Tarsus Pharmaceuticals, Inc. Mar 18, 2025 3 -$464K 4 Mar 20, 2025 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2025 4 $0 4 Mar 18, 2025 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 5, 2025 2 $0 4 Mar 7, 2025 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2024 4 -$136K 4 Mar 19, 2024 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Nov 29, 2023 3 -$136K 4 Dec 1, 2023 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 21, 2023 3 -$13.5K 4 Mar 23, 2023 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 17, 2023 2 -$9K 4 Mar 21, 2023 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2023 3 -$4.53K 4 Mar 17, 2023 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 8, 2023 2 $0 4 Mar 10, 2023 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Dec 2, 2022 1 -$19.5K 4 Dec 6, 2022 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Nov 29, 2022 4 -$39K 4 Dec 1, 2022 General Counsel
TARS Tarsus Pharmaceuticals, Inc. Mar 9, 2022 3 $0 4 Mar 11, 2022 General Counsel